Technical Analysis for CMTA - Clementia Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade B 14.67 4.79% 0.67
CMTA closed up 4.79 percent on Friday, February 15, 2019, on 3.47 times normal volume.

Earnings due: Feb 27

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical CMTA trend table...

Date Alert Name Type % Chg
Feb 15 Pocket Pivot Bullish Swing Setup 0.00%
Feb 15 Volume Surge Other 0.00%
Feb 15 Bollinger Band Squeeze Range Contraction 0.00%
Feb 15 BB Squeeze + Upper Band Touch Range Contraction 0.00%
Feb 15 Above Upper BB Strength 0.00%
Feb 15 Gapped Up Strength 0.00%
Feb 15 Upper Bollinger Band Touch Strength 0.00%
Feb 14 Pocket Pivot Bullish Swing Setup 4.79%
Feb 14 Bollinger Band Squeeze Range Contraction 4.79%
Feb 14 Narrow Range Bar Range Contraction 4.79%

Older signals for CMTA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Clementia Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical need. Its lead product candidate, palovarotene, is an oral small molecule that binds and activates retinoic acid receptor gamma (an RARg agonist), and has activity in preventing abnormal new bone formation as well as scar tissue formation (or fibrosis) in a variety of tissues in animal models. It is developing palovarotene for the treatment of Fibrodysplasia Ossificans Progressiva (FOP) and Multiple Osteochondroma (MO). Its programs focus on diseases involving tissue transformation via retinoic acid receptors (RARs). The Company also has an eye drop formulation of palovarotene that can potently increase tear production and decrease corneal damage.
Diseases Chemical Compounds Stage Biopharmaceutical Rare Diseases Cell Biology Scar Fibrosis Intracellular Receptors Pyrazoles Transcription Factors
Is CMTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 19.58
52 Week Low 8.1
Average Volume 48,410
200-Day Moving Average 12.682
50-Day Moving Average 12.94
20-Day Moving Average 13.6625
10-Day Moving Average 13.883
Average True Range 0.8898
ADX 24.79
+DI 23.2424
-DI 10.5684
Chandelier Exit (Long, 3 ATRs ) 12.2806
Chandelier Exit (Short, 3 ATRs ) 14.8494
Upper Bollinger Band 14.4412
Lower Bollinger Band 12.8838
Percent B (%b) 1.15
BandWidth 11.399085
MACD Line 0.2838
MACD Signal Line 0.2272
MACD Histogram 0.0565
Fundamentals Value
Market Cap 447.83 Million
Num Shares 30.5 Million
EPS -472.48
Price-to-Earnings (P/E) Ratio -0.03
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.65
Resistance 3 (R3) 15.63 15.29 15.48
Resistance 2 (R2) 15.29 15.04 15.30 15.43
Resistance 1 (R1) 14.98 14.89 15.14 15.00 15.37
Pivot Point 14.64 14.64 14.72 14.65 14.64
Support 1 (S1) 14.33 14.39 14.49 14.35 13.97
Support 2 (S2) 13.99 14.24 14.00 13.91
Support 3 (S3) 13.68 13.99 13.86
Support 4 (S4) 13.70